Surfactant improves lung function and mitigates bacterial growth in immature ventilated rabbits with experimentally induced neonatal group B streptococcal pneumonia

Arch Dis Child Fetal Neonatal Ed. 1997 Jan;76(1):F3-8. doi: 10.1136/fn.76.1.f3.

Abstract

Aims: To study the influence of surfactant on lung function and bacterial proliferation in immature newborn rabbits with experimental group B streptococcal (GBS) pneumonia.

Methods: Preterm rabbit fetuses (gestational age 28 days) underwent tracheotomy and were mechanically ventilated in a warmed body plethysmograph that permitted measurement of lung-thorax compliance. Fifteen minutes after the onset of ventilation the animals received either GBS or saline intratracheally; at 30 minutes, a bolus of saline or 200 mg/kg of a porcine surfactant (Curosurf) was administered via the airway. Bacterial proliferation was evaluated in lung homogenate at the end of the experiments and the results expressed as mean log10 cfu/g lung (SD). Animals receiving only saline (n = 20) or saline and surfactant (n = 20) served as controls.

Results: The average survival time was about three hours in all groups. Infected animals receiving surfactant (n = 22) had significantly less bacterial growth (9.09 (0.45) vs 9.76 (0.91)) and improved lung function (compliance: 0.61 (0.14) vs 0.34 (0.19) ml/kg. cm H2O) than infected rabbits receiving saline at 30 minutes (n = 22).

Conclusion: Surfactant improves lung function and mitigates bacterial growth in preterm rabbits infected with group B streptococci.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Biological Products*
  • Disease Models, Animal
  • Lung / physiopathology*
  • Lung Compliance
  • Phospholipids*
  • Pneumonia, Bacterial / physiopathology
  • Pneumonia, Bacterial / therapy*
  • Pulmonary Surfactants / therapeutic use*
  • Rabbits
  • Streptococcal Infections / physiopathology
  • Streptococcal Infections / therapy*
  • Streptococcus agalactiae* / growth & development

Substances

  • Biological Products
  • Phospholipids
  • Pulmonary Surfactants
  • poractant alfa